Are We Ready to Ride the Wave of Artificial Intelligence? 

Nov 18 2024
Convention Center: Room 29
11:00 AM - 12:30 PM
Captured

World Class Speakers

Ashley Spann, MD, MSACI
Presenter

Ashley Spann, MD, MSACI

Vanderbilt University Medical Center
AS
Presenter

Alexandra T Strauss, MD, PhD, MIE

Description

This session—held 2 years after the release of ChatGPT—covers updates and advancements in the applications of generative AI (GenAI) in liver diseases. The discussion builds on previous introductory sessions at The Liver Meeting 2023 and Digestive Disease Week 2024. Presenters explore advanced topics including: (1) AI alignment, ie, ensuring that an AI system’s objectives align with human values and goals, such as whether AI gives factually correct and safe answers in response to questions about liver diseases; (2) commercially available AI tools deployed within EHRs and adjacent to EHRs (eg, AI scribe technologies) that have a hepatology focus; and (3) human-computer interactions in GenAI relevant to applications in clinical hepatology.

 

Objectives

  • Describe the concept of AI alignment in the context of liver diseases.
  • Review commercially available AI tools that are deployed within EHRs and adjacent to EHRs that have a hepatology focus.
  • Summarize how patient-facing AI deployments, such as chatbots, will alter the patient-clinician relationship and interaction.
Chair

Jin Ge, MD, MBA

University of California, San Francisco
Chair

Howard (Tzu-Hao) Lee, MD

Baylor College of Medicine